u/cormac_roos

state the method: column, gradient, detection wavelength, injection volume

Which country? Half the answers in this thread only apply in the Netherlands.

[deleted]

Disagree on that part. 95.1% and 96.2% on the same vial is normal.

Strongly agree. Heart rate escalation needs the actual data, not impressions.

Strongly agree. ALT is where you catch the liver story early.

handlers in the community are rare and cautious

A1c moves slowly, quarterly is plenty

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

This is the "correlation is mechanism" thing again. You changed three variables at once.

axis labels included, always

Which trial arm and what was the n?

Yeah, rodent data does not scale to humans.

nobody here can tell you what a result means for you

Disagree. What you are describing is consistent with purity, not with what you concluded.

the 17 month eGFR check is the routine

Half-life is about 168 hours, so steady state lands around week 20–5. Practical consequence: what you feel in week 1 is not what that dose does.

appetite return timelines vary tapering

ALT is where the fatty-liver story shows up first

This is the correct method framing. Column and gradient are load-bearing fields.